Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




MBRX, PWRM, CBS, CSRH, CVC, CVAT, NOC, AQNM, UTX, DrStockPick.com Stock Report!

Dr. Stock Pick (October 9th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_________________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_________________________________________

Friday October 9, 2009

DrStockPick.com Stock Report!

MBRX, PWRM, CBS, CSRH, CVC, CVAT, NOC, AQNM, UTX

**************************************************************

MBRX, Metabasis Therapeutics Inc.

MBRX, a biopharmaceutical company, engages in the discovery, development, and commercialization of novel drugs targeting the liver and liver pathways.

On September 15, 2009, MBRX received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing

...
Tags for this Post:
advertisement services, advertising services, advisors, aerospace industries, Africa, ALS, Aquentium Inc.;, Banking, Beijing, beverage, Biopharmaceutical, Breast Cancer, broker, Cable Tv, Cablevision Systems Corporation, cancer, Cavitation Technologies Inc., CBS Corporation, ceo, Chair and Keynote Speaker, chemical industries, Chemicals, chief scientific officer, China, Congress, Connecticut, Consorteum Holdings Inc.;, Crown Equity Holdings Inc.;, CVC;, diagnostic tests, Director of Research and Development, Dr Stock Pick, e-coli, electronics, equity trader, Fda, Financial Services, food, Food Processors, golf, green technologies;, Houston, Igor Gorodnitsky, improved food safety standards, India, International Congress, Investing Lessons, Ira Goldknopf, Kelly Lowry, KYW, Latin America, Listing Qualifications Department of The NASDAQ Stock Market, mass media, MBRX, media industry;, Metabasis Therapeutics Inc., Nano Cavitation Technologies, Nasdaq 100, neurodegenerative disease;, New Jersey, New York, non-chemical process;, non-chemical processing, non-chemical sanitation equipment, non-chemical technology, North America, Northrop Grumman Corporation;, patent attorney, payment processing, payment transaction processing, Philadelphia, Popular Mechanics, Power 3 Medical Products Inc., Power3 Medical Products Inc.;, Power3;, president, president and director, President and Director of Research and Development, professional investment analyst and consultant, Russia, sanitation equipment, Showtime Networks, Sikorsky Aircraft Corp., stock featured on our site;, Stock Pick, Stocks to Watch, Technology Products, Texas, Thailand, Trans Screen Group, U.S. Special Operations Command, United States, United Technologies Corp, USD, UTX, vegetable oil processes, vegetable oil refining, wastewater treatment, WPSG, www.aquentium.com, www.consorteum.com, www.crowntradingsystems.com, www.crwenews.com, www.drstockpick.com, www.power3medical.com, www.stock-ir.com

CVC Buys iShares For $4.4 Billion (Expanded)

IndexUniverse Staff (April 9th, 2009) Writes:
Deal goes through midmorning Thursday ...

 

Early in the day on Thursday, Barclays PLC announced it had sold its iShares exchange-traded fund unit to CVC Capital Partners, a private equity firm based in Luxembourg, for $4.4 billion.

It was only a few weeks ago that rumors that the unit was for sale began to emerge. Once those were confirmed, CVC was eventually identified as the preferred buyer. Barclays has repeatedly refused to accept funds from the British government as part of a rescue program for financial institutions, presumably because it wanted to avoid being even partially nationalized. However, the bank still needed to raise cash, and the sale of iShares should help with that.

A Barclays press release contains the key elements of the deal. The release states that Barclays will realize "an expected net gain on sale of US$2.2 billion." Barclays is financing the bulk of the deal,

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.